Commercialisation Platform Overview
Grünbiotics is a pioneering, Australian-based nutritional science company. With a strong presence in the rapidly-expanding worldwide Medical Foods market, Grünbiotics is well placed to drive innovation and mature.
Our Medical Food products are firmly positioned within country-specific / regional markets, including “Food for Special Medical Purposes” (Codex Alimentarius Commission – FAO-WHO/UN, Australia and New Zealand, the European Union and China), “Food for Specified Health Uses” (in Japan) and “Medical Foods” (in the US).
As Medical Foods, Grünbiotics’ products are differentiated from both nutritional supplements and pharmaceuticals. That is, Medical Foods are foods used to address specialised nutritional requirements of people with certain disorders, diseases or medical conditions, where the requirements cannot be met from modifications to normal diet alone. Pharmaceuticals, on the other hand, are drugs for treating those who are ill. Nutritional supplements and functional foods are taken by healthy people to help maintain their level of health.
Grünbiotics has already achieved international success with Neurofolin®, and will soon be releasing a new Medical Food for Mild Cognitive Impairment / Alzheimer’s Dementia. We currently have a number of Medical Food products in the R&D pipeline and plan to further cement our presence in this burgeoning international market.
Grünbiotics and Commercialisation Activities
Market and Consumer Insights
Grünbiotics’ conducts stringent consumer / market research and demand validation activities prior to investing heavily in the R&D process in order to identify genuine demand, potential market size, available market share, financial feasibility, unmet consumer needs, identification of products that offer difference, and much more.
Research and Development
Grünbiotics teams up with the world’s best when it comes to R&D. We realise products that can really improve people’s lives are a result of strong research partners, evidence-based product development, renowned state-of-the-art research facilities and best-in-class researchers. Our R&D partners include Merck KGaA, The Florey Institute of Neuroscience and Mental Health (Melbourne, Victoria), Monash University and Oxford University researchers.
IP Protection and Management
Grünbiotics has proven capabilities in innovative research and proprietary product development in the Medical Nutrition space. Our evidence-based product development and clinical studies ensures we have been able to provide beneficial Medical Food products that produce reliable results and have gone through rigorous approval processes to gain formal registration and IP protection across numerous countries around the world.
Registrations and Approvals
Our business and Medical Nutrition products have navigated extremely complex and challenging approval processes. They are registered through IP Australia, the World Intellectual Property Organisation (WIPO) and the United States Patent and Trademark Office in a number of countries across Asia-Pacific and Europe, including Australia, New Zealand, China, Japan, South Korea, Singapore and the Philippines. Grünbiotics is an Australian registered business and, through our manufacturing partners, our products are produced under the following accreditations:
BRC Global Standard for Food Safety
CAC HACCPVER:2003 - CODEX HACCP
GMP (Good Manufacturing Practices)
Our products are compliant with regulations in Australia and overseas, including Food Standards Australia New Zealand (FSANZ), The European Food Safety Authority (EFSA), and the United States Food and Drug Administration (FDA). We comply with food labelling, presentation, advertising & marketing, nutrition and health claims, composition and contaminants and natural toxicants regulations.
Manufacturing and Quality Control
Our QC partners ensure the manufacturing of Grünbiotics’ products is robust, safe and stable. Performing significant quality checks, analysis and integrating QC into the entire manufacturing process, our QC is aligned with the world-class requirements of our partners – Merck KGaA and Mylan.
Sales, Marketing and Public Relations
Grünbiotics successfully operates in a unique landscape where target markets are simultaneously the health care professional and the product consumer. We partner with leading marketing and PR experts from around the world, making use of traditional and new media to actively engage health care professionals and customers and create positive brand recognition that is built on real results, trust and quality products. Our Licensee End-to-End Support Package (including Marketing & PR) assists strategic partners by providing tailored solutions, expertise, industry knowledge and budget constraint solutions (time and costs).
Licensing and Distribution
Grünbiotics offers partner firms a market pathway for our products through various licensing opportunities. Grünbiotics licensees deliver our products, use Grünbiotics’ trademarks and our business name, and leverage our resources, expertise and experience. We provide flexible agreements for our strategic partners and our trademarked and patent-pending medical nutrition products provide major competitive advantage to distributors.
To find out more about Grünbiotics, our current Medical Nutrition products or those currently in the R&D pipeline, please contact us:
Telephone: +613 8692-0006